Login/Sign Up
Oxaliage 50 mg Injection 25 ml
Oxaliage 50 mg Injection 25 ml is used to treat Colon and rectal cancer. It contains Oxaliplatin, which works by killing the cancer cells. Thereby, it helps treat cancer. Sometimes, Oxaliage 50 mg Injection 25 ml may cause side effects such as mild nausea, vomiting, diarrhoea, fever, and headache. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy and breastfeeding.
₹2340*
₹1989*
MRP ₹2340
15% CB
₹351 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Oxaliage 50 mg Injection 25 ml belongs to the group of medicines called platinum-containing antineoplastic agents used alone or in combination with other anti-cancer medicines to treat cancer of the large bowel/intestine (advanced colon or colorectal cancer).
Oxaliage 50 mg Injection 25 ml contains Oxaliplatin, which works by killing the cancer cells. Thereby, it helps treat cancer.
In some cases, Oxaliage 50 mg Injection 25 ml may cause side effects such as mild nausea, vomiting, diarrhoea, fever, and headache. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
Do not use Oxaliage 50 mg Injection 25 ml if you are breastfeeding. Consult a doctor immediately if you become pregnant during treatment with Oxaliage 50 mg Injection 25 ml. This medicine is not recommended for children as safety and effectiveness have not been established. Inform your doctor about your health condition and medications to rule out any side effects/interactions.
Oxaliage 50 mg Injection 25 ml contains Oxaliplatin, which belongs to the group of medicines called platinum-containing antineoplastic agents used to treat stage III colon cancer after complete removal of the primary tumour and metastatic cancer of the colon and rectum. It is used in combination with other anti-cancer medicines, such as 5-fluorouracil and folinic acid. Oxaliage 50 mg Injection 25 ml works by killing the cancer cells. Thereby, it helps treat cancer. Oxaliage 50 mg Injection 25 ml may also be used with other medicines to prevent colon cancer from spreading in patients who have had surgery to remove the tumour.
Do not use Oxaliage 50 mg Injection 25 ml if you are allergic to any of its components, if you are breastfeeding, have a low blood cell count, have severe kidney problems, tingling and numbness in the fingers/toes, and have difficulty performing fragile tasks, such as buttoning clothes. Inform the doctor if you ever suffered an allergic reaction to platinum-containing medicines, have mild/moderate kidney problems, liver problems or abnormal liver function tests during therapy, or heart disorders like prolongation of the QT interval (abnormal electrical signal), an irregular heartbeat, or a family history of heart problems. Seek immediate medical attention if you experience symptoms of an allergic reaction (rash, itching, hives, reddening of the skin, hoarseness, difficulty breathing or swallowing, feeling as if your throat is closing, dizziness, swelling of the lips and tongue, lightheadedness, or fainting), unpleasant sensation in the throat, rhabdomyolysis (muscle pain and swelling), nerve problems (sensitivity to cold temperature or cold objects, pain, tingling or burning sensation), Posterior Reversible Encephalopathy Syndrome (headache, confusion, seizures, vision problems), myelosuppression (chills or shivering, burning or pain on urination, pain on swallowing, sore throat, cough with mucus, persistent diarrhoea), lung problems (shortness of breath, wheezing, cough), or bleeding problems (vomit that looks like coffee grounds or bloody vomit, pink or brown urine, weakness, dizziness, changes in speech, confusion, unexplained bleeding or dark-coloured/tarry stools).
Drug-Drug Interactions: Inform the doctor if you are taking medicines that prolong QT interval (antiarrhythmic agents), nephrotoxic products, or anti-coagulants.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Inform the doctor if you have an infection, lung, liver or kidney problems, bleeding problems, heart problems (long QT syndrome, irregular/slow heartbeat), or changes in electrolyte levels.
Colon and rectal cancer: It is a cancer of the colon or rectum. Colorectal cancer is the growth of cells that form in the lower end of the digestive tract. Most of these cancers begin as polyps (non-cancerous growths). Symptoms may include abdominal discomfort, blood in the stool, and changes in bowel habits like constipation or diarrhoea.
Alcohol
Consult your doctor
It is not known if alcohol affects Oxaliage 50 mg Injection 25 ml. Please consult your doctor.
Pregnancy
Unsafe
Oxaliage 50 mg Injection 25 ml may cause foetal harm. Therefore, avoid becoming pregnant during treatment with Oxaliage 50 mg Injection 25 ml.
Breast Feeding
Unsafe
Breastfeeding is not recommended during treatment with Oxaliage 50 mg Injection 25 ml and for three months after the last dose.
Driving
Caution
Oxaliage 50 mg Injection 25 ml may cause dizziness or vision problems. Avoid driving or operating machinery if you experience any side effects that might lessen your ability to do so.
Liver
Consult your doctor
If you have a history of liver disease, inform your doctor before receiving Oxaliage 50 mg Injection 25 ml.
Kidney
Caution
Oxaliage 50 mg Injection 25 ml should not be used if you have severe kidney disease. If you have mild or moderate kidney disease, inform your doctor before receiving Oxaliage 50 mg Injection 25 ml.
Children
Unsafe
Oxaliage 50 mg Injection 25 ml is not recommended for children as safety and effectiveness have not been established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes